These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 26692235)

  • 21. Preparation, characterization and in vivo evaluation of formulation of repaglinide with hydroxypropyl-β-cyclodextrin.
    Liu M; Cao W; Sun Y; He Z
    Int J Pharm; 2014 Dec; 477(1-2):159-66. PubMed ID: 25455768
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoglycemia during the Concomitant Use of Repaglinide and Clopidogrel in an Elderly Patient with Type 2 Diabetes and Severe Renal Insufficiency.
    Takayama K; Fujii K; Yamaguchi H; Miyoshi Y; Uehara Y; Nagata S; Obata Y; Kosugi M; Hazama Y; Yasuda T
    Intern Med; 2021; 60(6):905-910. PubMed ID: 33716254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral combination therapy: repaglinide plus metformin for treatment of type 2 diabetes.
    Raskin P
    Diabetes Obes Metab; 2008 Dec; 10(12):1167-77. PubMed ID: 18494804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with repaglinide in patients with non-insulin-dependent diabetes mellitus.
    Shapiro MS; Abrams Z; Lieberman N
    Isr Med Assoc J; 2005 Feb; 7(2):75-7. PubMed ID: 15729954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of repaglinide versus glyburide on postprandial glucose and insulin values in elderly patients with type 2 diabetes.
    Meneilly GS
    Diabetes Technol Ther; 2011 Jan; 13(1):63-5. PubMed ID: 21175273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of gemfibrozil on repaglinide pharmacokinetics persists for at least 12 h after the dose: evidence for mechanism-based inhibition of CYP2C8 in vivo.
    Tornio A; Niemi M; Neuvonen M; Laitila J; Kalliokoski A; Neuvonen PJ; Backman JT
    Clin Pharmacol Ther; 2008 Sep; 84(3):403-11. PubMed ID: 18388877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repaglinide dose response? A clinician's viewpoint.
    Strange P; Goldberg RB
    Diabetes Technol Ther; 2000; 2(1):119-21. PubMed ID: 11467310
    [No Abstract]   [Full Text] [Related]  

  • 29. The CYP2C8 inhibitor trimethoprim increases the plasma concentrations of repaglinide in healthy subjects.
    Niemi M; Kajosaari LI; Neuvonen M; Backman JT; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Apr; 57(4):441-7. PubMed ID: 15025742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of nateglinide and repaglinide administered intracerebroventricularly on the CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
    Brain Res Bull; 2014 May; 104():36-41. PubMed ID: 24704461
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metformin overdose-induced hypoglycemia in the absence of other antidiabetic drugs.
    Al-Abri SA; Hayashi S; Thoren KL; Olson KR
    Clin Toxicol (Phila); 2013 Jun; 51(5):444-7. PubMed ID: 23544622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L; Bundgaard C; Garmer M; Jensen B
    Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of effect of bezafibrate and fenofibrate on the pharmacokinetics and pharmacodynamics of repaglinide.
    Kajosaari LI; Backman JT; Neuvonen M; Laitila J; Neuvonen PJ
    Br J Clin Pharmacol; 2004 Oct; 58(4):390-6. PubMed ID: 15373931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk of Hypoglycemia and Concomitant Use of Repaglinide and Clopidogrel: A Population-Based Nested Case-Control Study.
    Wei Y; Lin FJ; Lin SY; Wang CC
    Clin Pharmacol Ther; 2019 Dec; 106(6):1346-1352. PubMed ID: 31216051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe hypoglycemia caused by a small dose of repaglinide and concurrent use of nilotinib and febuxostat in a patient with type 2 diabetes.
    Komatsu H; Enomoto M; Shiraishi H; Morita Y; Hashimoto D; Nakayama S; Funakoshi S; Hirano S; Terada Y; Miyamura M; Fujimoto S
    Diabetol Int; 2020 Oct; 11(4):388-392. PubMed ID: 33088647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dilemma of diagnosing sulphonylurea overdose in children: deliberations and considerations before reaching a diagnosis.
    Gopal-Kothandapani JS; Wright KP; Sithambaram S; Natarajan A
    BMJ Case Rep; 2017 Aug; 2017():. PubMed ID: 28847991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet.
    Szlatenyi CS; Capes KF; Wang RY
    Ann Emerg Med; 1998 Jun; 31(6):773-6. PubMed ID: 9624321
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intentional massive insulin overdose: recognition and management.
    Roberge RJ; Martin TG; Delbridge TR
    Ann Emerg Med; 1993 Feb; 22(2):228-34. PubMed ID: 8427437
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serious hypoglycemia associated with misuse of repaglinide.
    Flood TM
    Endocr Pract; 1999; 5(3):137-8. PubMed ID: 15251685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclosporine A increases plasma concentrations and effects of repaglinide.
    Backman JT; Kajosaari LI; Niemi M; Neuvonen PJ
    Am J Transplant; 2006 Sep; 6(9):2221-2. PubMed ID: 16869799
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.